Enzalutamide leads to 40% lower risk of death in prostate cancer
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Experts urge early detection & better access to care
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The hospital hosted a two-day event with top internal and external faculty and medical experts
Subscribe To Our Newsletter & Stay Updated